HLA-DR Antikörper (Biotin)
Kurzübersicht für HLA-DR Antikörper (Biotin) (ABIN3071873)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Verwendungszweck
- Anti-HLA-DR Biotin Antibody
-
Produktmerkmale
- The L243 reacts with human HLA-DR antigen which is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes, activated natural killer (NK) lymphocytes, and human progenitor cells. HLA-DR is also present on thymic epithelium, B lymphocyte dependent areas of spleen and lymph node, and B cell lymphomas.
-
Aufreinigung
- Purified
-
Reinheit
- >95 %
-
Immunogen
- Human B lymphocytes
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS pH 7.2, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 2-8°C, Conjugated antibodies should never be frozen.
-
-
- HLA-DR
-
Andere Bezeichnung
- HLA-DR
-
Gen-ID
- 3122, 3123
-
NCBI Accession
- NM_019111
-
UniProt
- P01903
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-